JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menetski, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menetski, J. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 11, 7619-7625, March 17, 2000


The Structure of the Nuclear Factor-kappa B Protein-DNA Complex Varies with DNA-binding Site Sequence*

Joseph P. MenetskiDagger

From the Department of Molecular Biology, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert, Ann Arbor, Michigan 48105

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Transcriptional regulation of many immune responsive genes is under the control of the transcription factor NF-kappa B. This factor is found in cells as a dimer which can contain any two members of the Rel family of proteins (p50, p65, p52, c-Rel, and RelB). The different dimers show distinct preferences for DNA-binding site sequences. To understand the relationship between the DNA binding properties of the dimer forms and transcriptional activation, the physical properties of the complexes of p50 and p65 with DNA have been analyzed. Comparison of apparent DNA binding affinity showed differences in selectivity of DNA-binding site sequence. The ionic strength dependence of apparent binding affinity has shown that the number of ionic interactions in the protein-DNA complex depends on the DNA-binding site sequence and the dimer form, which are consistent with changes in the structure of the protein-DNA complex. Using a fluorescent technique to measure DNA structure changes, protein binding does not appear to alter the structure of the DNA-binding site within the limits of detection. These results are consistent with a change in protein structure that may result in activation differences due to alternative interactions with other transcription proteins.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The transcription factor NF-kappa B has been shown to activate transcription from many genes involved in the immune response (for review, see Ref. 1) and from several viral promoters (HIV1 (2) and cytomegalovirus (3)). The central role for NF-kappa B in inflammation has been confirmed in mice lacking the p50 or the RelB subunit of NF-kappa B. These animals show severe alterations in their response to immune challenge (4, 5). In addition, p65-deficient B- and T-cells show severe reductions in cellular activation (6). The active DNA binding form of NF-kappa B is a dimer and can consist of any combination of five different NF-kappa B/Rel protein subunits (p50, p52, p65, c-Rel, and RelB) (1, 7). Many previous studies have shown that dimers of the different monomeric forms show differences in sequence selectivity. Early studies looking at p50 and p65 DNA binding specificity suggested that the p65 subunit extended the specificity of p50 (8). In studies of DNA-binding site selection, Kunsch et al. (9) have shown defined selectivities for each dimer form using electrophoretic mobility shift assays. Perkins et al. (10) have shown that subunit composition could influence transcriptional activation in transfection assays in Jurkat T-cells. It has also been shown that the 3'-half site of a NF-kappa B element has a profound effect on the species of NF-kappa B dimer that binds to that site (11). Finally, Schmid et al. (12) have shown that the p50 and p49 subunits of NF-kappa B have distinct binding properties and function differently on different DNA-binding sites. Thus, there is clear evidence that there are differences between the protein-DNA complexes that depend on the dimer form and the DNA sequence in the complex. However, there have been few studies to identify and characterize what the structural differences could be between these complexes.

The structures of the p50, p52, p65 homodimer, and p50/p65 heterodimer protein-DNA complexes have been reported (13-17) and have provided a great deal of insight into the mechanisms of specificity of these protein-DNA interactions. It is clear that there are many direct contacts between the protein and DNA in the DNA-binding domain that afford specificity to a consensus DNA-binding site. However, there are still many questions about how the observed structures relate to transcriptional activity. Although the structures reported show differences in the DNA-binding domain, it is unclear if there are any changes in the DNA-binding domain when the protein is bound to different DNA-binding sites. These structures were solved with a limited number of DNA sequences, so any changes in complex structure that depend on the DNA sequence in the site cannot be defined. Understanding these changes in structure are particularly interesting as the residues that interact with the DNA in a sequence specific manner are found in a portion of the protein that is likely to be flexible owing to its location at the end of a beta -sheet structure (14). Because, the differences in activity observed when bound to alternate sites is likely to be biologically significant, we have analyzed the physical characteristics of p50/p50, p65/p65, and p50/p65 dimer binding to several DNA-binding site sequences.

Using both nitrocellulose filter binding and fluorescence polarization, the apparent dissociation constants for protein-DNA site interactions were determined under various conditions. This analysis has identified several interesting aspects of the NF-kappa B-DNA complexes. The data show that the p50 homodimer can bind to nonspecific DNA with a higher apparent affinity than the p65 homodimer. Also, the NF-kappa B-DNA interaction is sensitive to the anion in the buffer, which suggests that ions are released from the protein upon binding. Finally the number of ions released upon complex formation is dependent on the DNA sequence of the binding site and the dimer form. This last result is consistent with the hypothesis that the conformation of the protein-DNA complex can vary with DNA-binding site sequence.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein Expression and Purification-- The GSTp50 and GSTp65 prokaryotic expression plasmids were a generous gift of Drs. Neal Perkins and Gary Nabel (18). GST fusion proteins were expressed and purified essentially as described by Perkins et al. (18). Briefly, cells were grown in LB with 100 µg/ml ampicillin for 3-5 h and induced with 1 to 3 mM isopropyl-1-thio-beta -D-galactopyranoside for 1 h. Induced cells were washed and resuspended in lysis buffer (20 mM Hepes (pH 7.5), 10 mM MgCl2, 20% glycerol, 0.1% Nonidet P-40, 1 mM dithiothreitol, 10 µg/ml DNase I, and 0.5 mM phenylmethylsulfonyl fluoride) and sonicated. Cellular debris was removed by centrifugation at 45,000 × g for 10 min. Glutathione-agarose purification was done as described by the manufacturer (Amersham Pharmacia Biotech). Homodimer binding experiments were done using the glutathione S-transferase (GST) fusion proteins without further purification. Heterodimer binding experiments were carried out after incubation of equimolar amounts of GSTp50 and GSTp65 for 30 min at 37 °C (19). TATA-binding protein was a gift of Dr. B. Markham (Parke-Davis Pharmaceutical Research).

DNA Binding Competition Assay-- Protein-DNA complex formation was measured by the method of Riggs et. al. (20) as described briefly below. DNA probe (32P-beta -interferon NF-kappa B site 20-mer; 10 nM) was mixed with variable amounts of the competitor DNA prior to the addition of the GST-Rel fusion proteins. DNA-binding site sequences used are shown in Table I. Competitor DNA concentration varied from zero to 10 µM. Rel protein dimers (50 nM p50 homodimer, p65 homodimer, or the p50/p65 heterodimer) were incubated with the beta -interferon probe and cold competitors in binding buffer (10 mM Tris acetate (pH 7.4), 10 mM magnesium acetate, 0.1 mM dithiothreitol, 0.1 mM EDTA, 5% dimethyl sulfoxide, and 50 µg/ml bovine serum albumin) at 37 °C for 30 min. Following the incubation period, each reaction was filtered through a nitrocellulose membrane (Immobilon nitrocellulose 96-well filter plate; Millipore, Bedford, MA) which was pre-equilibrated with filter buffer (10 mM Tris acetate (pH 7.4), 10 mM magnesium acetate, 0.1 mM EDTA, 5% dimethyl sulfoxide). Each filter plate was then washed with filter buffer and dried. Filter plates were counted using a Microbeta 1450 liquid scintillation counter (Wallac, Gaithersburg, MD). The degree of competition was determined as the percentage of specific counts retained on the filter in the presence of competitor compared with that in the absence of competitor. Each experimental point was done in triplicate and the average and error are reported for representative experiments (average error was less than 5%). The half-maximal concentration of competition was determined by nonlinear least squares fitting of the data sets to a simple logistic plus slope using the Origin analysis software package (MicroCal, MA).

                              
View this table:
[in this window]
[in a new window]
 
Table I
NF-kappa B site sequence variants used in this study
DNA sites used in this report are shown. In each case, the decamer sequence was synthesized with the flanking regions shown. Complementary oligonucleotides were made to generate a blunt end.

Fluorescence Polarization DNA Binding Experiments-- Oligonucleotides for the beta -interferon, human Ig-kappa , and HIV-binding site were synthesized with a single primary amine (Aminolink; ABI) at the 5' end of the 18-mer using an ABI 294 DNA synthesizer. The primary amine was then conjugated to fluorescein using NHS-fluorescein (Molecular Probes). The fluorescein-conjugated oligonucleotide was then purified from unreacted oligonucleotide using gel electrophoresis. DNA was removed from the gel slice by crush and soak in 10 mM Tris-HCl (pH 7.5), 1 mM EDTA buffer. Double stranded DNA-binding site was then prepared by reanealing to an unlabeled complementary oligonucleotide and again purified by gel electrophoresis. The annealed binding site was then used without further purification at a concentration of 2 nM for subsequent binding experiments unless otherwise noted. Polarization was measured using a Beacon 2000 fluorescence polarization system (PanVera, Madison, WI). Experiments were done in polarization binding buffer (20 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 0.1 mM dithiothreitol, 50 µg/ml bovine serum albumin and indicated concentration of NaCl or sodium acetate) at 37 °C. Labeled binding site was added to 0.5 ml of buffer in 10 × 75-mm tubes and the initial polarization reading was taken. Protein aliquots were then added to the tube and additional readings were taken until the readings did not change (within 2 min) and the last 2 readings were averaged in the data shown. The data from these experiments was plotted and fit to a hyperbola using the nonlinear curve fitting functions of Origin analysis software package (MicroCal, MA).

Fluorescence Resonance Energy Transfer Measurement for DNA Deformation-- DNA structure change was measured using oligonucleotide-binding sites labeled with both fluorescein and rhodamine at opposite ends using the same procedure as described above, except a rhodamine (Molecular Probes) labeled oligonucleotide was used instead of reannealing with an unlabeled oligonucleotide. A binding site length of 18 base pairs was used because some energy transfer was observed in the unbound DNA which was significantly increased in the presence of TATA-binding protein (TBP) in substrate containing the TATA-binding site. Fluorescence measurements were made using an SLM-Aminco SPF-500C spectrofluorimeter in binding buffer (20 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 0.1 mM dithiothreitol, 50 µg/ml bovine serum albumin and indicated concentration of NaCl or sodium acetate) at 25 °C.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Different NF-kappa B Forms Show Different Selectivity for DNA-binding Sites-- Previous studies have shown that the alternative dimer forms prefer different DNA-binding site sequences (9) that can effect transcriptional activation (10).2 We have analyzed the relative affinities of several DNA-binding sites for p50/p50, p65/p65, or p50/p65 using purified fusion proteins and defined flanking sequences. Fig. 1 shows data for p65 homodimer and 3 different competitor DNA-binding sites. The data have been normalized to the concentration required to inhibit binding to 50% of the highest affinity competitor (Table II). As expected from previous studies, the order of apparent affinities for p50 homodimer is different from that of p65 homodimer. The apparent affinity for p65 homodimer binding to any of these sites varies over a 30-fold concentration range, while the range of apparent affinity for p50 homodimer with the same DNA-binding sites is less than 10-fold. The p50/p65 heterodimer order of apparent affinity is similar to that of p65, however, the range of apparent affinities for the p50/p65 heterodimer is smaller than that of p65 homodimer. Thus, in this set of binding sites, the p65 monomer seems to define the selectivity for the p50/p65 heterodimer complexes. Also, the smaller difference in apparent affinity observed for p50 homodimer, compared with p65 homodimer, suggests that p65 binding is more sensitive to DNA-binding site sequence than p50, for the DNA-binding sites tested.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Selectivity for DNA-binding sites by different NF-kappa B dimer forms. Homodimer of p65 was incubated with labeled beta -interferon probe and increasing concentration of cold competitor was added to the reaction as described under "Experimental Procedures." Competitor titration for p65 homodimer-beta -interferon complex with beta -interferon (circles), hu Igkappa (squares), and HIV long terminal repeat (triangles).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Comparison of DNA-binding site preference between rel-protein dimers
Binding experiments were done as described under "Experimental Procedures." The data is reported as the IC50 values normalized to the competitor with the highest apparent affinity within a dimer form. The list is arranged in order of highest to lowest apparent affinity for the p65 homodimer. Sequences are shown in the forward orientation (as found in their endogenous promoters) for convenience.

The Apparent Affinity of the p50 Homodimer for Nonspecific DNA Is Higher Than Observed for the p65 Homodimer-- The filter binding assay is useful for surveying many different sites, but a solution binding assay is preferred for detailed binding studies. Fluorescence polarization has been used to study protein association with fluorescently labeled oligonucleotide-binding sites. Labeled DNA alone shows low fluorescence polarization in solution (typically ~60-80 millipolarization units). Upon addition of protein, the polarization increases to ~180-200 millipolarization units for the protein-DNA complex. Previous experiments in this laboratory have shown that the cellular activity of the human Igkappa , beta -interferon, and the HIV NF-kappa B DNA-binding sites are very different depending on the dimer composition,3 so these sites were chosen for examination. As shown in Fig. 2A, increasing the protein concentration increases the observed fluorescence polarization. This change can be observed for the three forms of NF-kappa B that have been tested (p50/p50, p50/p65, and p65/p65). For each site the starting polarization value of free DNA site was constant, however, the three sites did show slightly different polarization in the absence of protein (Igkappa  = ~95, HIV = ~90, and interferon = ~110). The polarization value of free DNA-binding site has been subtracted from each data point for analysis. The data from the filter binding experiments showed that there was less of a change in affinity with binding site for p50 than observed for p65. This observation can be interpreted to suggest that p50 is less binding site selective than p65. Since selectivity is related to the difference between the affinity of the protein to nonspecific sites compared with that for specific sites, the ability of p50 homodimer and p65 homodimer to bind to an oligonucleotide that does not contain a consensus NF-kappa B-binding site was measured. As shown in Fig. 2B, the fluorescence polarization of the nonspecific DNA-binding site increased with increasing concentration of p50 homodimer. A small change was observed only at high concentrations of p65 homodimer, suggesting that, under these conditions, p50 homodimer shows a higher apparent affinity for nonspecific DNA than p65 homodimer. These data can be compared with binding to a specific site and under the conditions tested, the difference between the binding affinity of p50 homodimer for a nonspecific site compared with a specific site is approximately 100-1,000, while that for p65 homodimer binding affinity is at least 1,000-10,000.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 2.   A, NF-kappa B DNA binding can be measured using fluorescence polarization. Recombinant NF-kappa B (p50 or p65) was added to fluorescein labeled DNA-binding site (18-mer) as described under "Experimental Procedures" at the protein concentrations shown. B, the p50/p50 homodimer binds to a nonspecific DNA-binding site with a higher apparent affinity than the p65/p65 homodimer. Polarization experiments were done, as described under "Experimental Procedures," using a nonspecific (mutant) NF-kappa B-binding site using either p50 homodimer (circles) or p65 homodimer (squares).

p50 and p65 DNA Binding Affinity Is Sensitive to the Ionic Strength and Anionic Component in the Buffer-- The ionic dependence of NF-kappa B binding to the human Igkappa , beta -interferon, and the HIV NF-kappa B DNA-binding sites have been determined. Since, the relationship between the apparent dissociation constant and the ionic strength is related to the net number of ions displaced during complex formation (21, 22), differences in ionic strength dependence suggest differences in the structure of the protein-DNA complex. To understand the physical properties of the different protein-DNA complexes, the ionic strength dependence of DNA binding was determined for each of the protein dimer form and the different DNA-binding sites. The results from p50 titration of the beta -interferon DNA-binding site are shown in Fig. 3 at increasing sodium acetate concentrations. It is clear from these results that increasing the sodium acetate concentration increases the amount of protein required to approach saturation of the binding site. These data have been fit to determine the apparent dissociation constants KD,app. As described elsewhere (23), the slope of the log K versus the log monovalent cation is equal to m'psi , where m' is the number of direct ionic interactions and psi  represents the number of thermodynamically bound cations to the polyanion. The log-log analysis for p50 or p65 homodimer or the p50/p65 heterodimer with the human Igkappa , beta -interferon, or the HIV NF-kappa B DNA-binding site is shown in Fig. 4. The slopes from the data determined using the interferon (Fig. 4A) and HIV (Fig. 4B) sites are consistently 3-4 (Table III), for all of the protein forms tested. Interestingly, the human Igkappa site (Fig. 4C) shows a difference in the slopes observed with the p65 homodimer (3.4) compared with the p50 homodimer or the p50/p65 heterodimer (6.0 and 6.1, respectively). These data suggest that more ions are displaced upon complex formation with p50. Thus, the complexes formed with the human Igkappa site must be structurally different in the complexes containing p50 compared with those formed with p65 alone.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Ionic strength affects apparent affinity of the NF-kappa B-DNA complex. Binding experiments are shown for p50/p50 titration of the beta -interferon DNA-binding site at increasing sodium acetate concentrations (50 mM, squares; 100 mM, circles; 150 mM triangles) as described under "Experimental Procedures." The initial polarization has been subtracted from each point so that the initial reading is zero to allow curve fitting.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 4.   Log-log analysis of apparent affinity sensitivity to ionic strength for several NF-kappa B-DNA complexes. Data are shown for the beta -interferon (A), HIV long terminal repeat (B), hu Igkappa /E-selectin (C), or nonspecific (D) DNA-binding sites using p50/p50 (circles), p65/p65 (triangles), or p50/p65 (squares). All data were generated using standard conditions as described under "Experimental Procedures."

                              
View this table:
[in this window]
[in a new window]
 
Table III
Ionic strength dependence of NF-kappa B binding to specific and nonspecific DNA binding sites
The data shown in Fig. 4 have been analyzed to determine the slope of the line for each data set and is reported. Binding reactions were done as described under "Experimental Procedures" for each dimer form and DNA-binding site.

Because the p50 homodimer can bind to nonspecific DNA with an appreciable affinity, the ionic strength dependence of this interaction could also be determined. Apparent DNA binding affinity of p50 binding for a non-NF-kappa B-binding site were determined at several sodium acetate concentrations and the results were analyzed in a log-log analysis. As shown in Fig. 4D, the apparent affinity of p50 homodimer for nonspecific DNA shows a reduced dependence on ionic strength compared with the specific site data (slope = 1.4). These results suggest that the contacts in the nonspecific DNA complex are not exactly the same as those found in the specific complex. Several reports have suggested that the anionic component of the buffer can effect binding affinity. In addition, the anion can also be found to effect the slope in a log-log analysis, suggesting that some of the ions displaced upon binding are anions (24, 25). Analysis of the effect on the anionic component on p50 homodimer binding is shown in Fig. 5, however, similar data have been obtained for p65 homodimer. Substitution of chloride for acetate significantly reduces the apparent affinity of p50 homodimer for DNA. However, the slope of the log-log analysis is the same for chloride or acetate. Thus, although the apparent affinity of DNA binding is affected the net number of ions displaced is unchanged.


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 5.   NF-kappa B binding to DNA is sensitive to the anion in the binding buffer. Apparent dissociation constants were obtained in buffer containing varying concentrations of NaCl or sodium acetate, as described under "Experimental Procedures." The log of the apparent dissociation constant is plotted versus the log of the monovalent cation (Na+).

Binding of p50 or p65 to the beta -Interferon or the Human Igkappa Does Not Significantly Effect Bending of the Site as Measured by Fluorescence Resonance Energy Transfer-- Since the ionic strength dependence data suggest that there is a difference in the structure of the protein-DNA complex, the molecular change could be in a change in the DNA, a change in the protein or both. NF-kappa B binding to DNA has been shown to bend DNA or not bend DNA depending on the report and the method of measurement. The structure of the DNA-binding site in solution can be determined using fluorescence resonance energy transfer between a fluorescence donor and acceptor at opposite ends of the DNA, as changes in the end to end distance of the oligonucleotide would be expected to accompany bending (26-29). Using fluorescein and rhodamine as fluorescence donor and acceptor, respectively, we have measured changes in DNA bending of short oligonucleotides (18-mers) containing a single DNA-binding site in solution. As a control for the technique, we have also measured transfer using an oligonucleotide containing a TATA-binding site and TBP, which is known to bend upon protein binding (30). As shown in Fig. 6A, the spectrum of the double-labeled TATA site DNA, in the absence of TBP, shows a slight transfer as seen in the small peak at 600-620 nm. Addition of TBP significantly increases the transfer to the acceptor and increases the peak in this region. There is also a strong decrease in the fluorescence associated with fluorescein, the donor, as is expected with increased transfer efficiency. Since, a difference was observed in the ionic strength dependence of p50-human Igkappa and interferon-binding site, these complexes were tested for changes in fluorescence energy transfer. As shown, binding of p50 has no effect on the overall fluorescence energy transfer observed for the human Igkappa or the interferon DNA-binding site (Fig. 6, B and C, respectively). These experiments are done under conditions where binding occurs at the protein concentrations tested and this has been verified using polarization. These data suggest that protein binding to this oligonucleotide does not make a net change in the end to end distance of the oligonucleotide. These results are consistent with the hypothesis that the structure of the DNA molecule does not change substantially in these experiments.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 6.   Fluorescence resonance energy transfer (FRET) to assess changes in DNA structure upon NF-kappa B binding. Oligonucleotide binding sites were 5'-labeled with fluorescein (donor) and rhodamine (acceptor) to measure changes in distance due to structural changes in the DNA. Experiments were done at 10 nM p50, or 35 nM TBP and 2 nM DNA-binding site. A, TBP binding to TATA-binding site. B, NF-kappa B binding to beta -intereferon, or C, hu Igkappa /E-selectin site upon addition of p65. Emission spectra are shown in the absence of protein (solid line) or presence of protein (dashed line).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this report, we assess the biochemical characteristics of NF-kappa B-DNA complex formation with several different sites. These analysis has lead to several conclusions. The p50 homodimer shows less selectivity of DNA-binding site sequence than the p65 homodimer. Also, the ionic strength dependence of complex formation is dependent on both the NF-kappa B dimer form and the DNA-binding site sequence. Finally, the apparent affinity of the NF-kappa B protein for DNA is influenced by the anionic component of the buffer. This type of physical data, along with models of the protein from x-ray crystallographic studies is necessary for understanding the determinants of DNA binding specificity and how they relate to the structure of the protein-DNA complex.

While studying DNA-binding site selectivity, the interaction with nonspecific DNA has also been addressed. The data show that p50 binds to nonspecific DNA with a higher apparent affinity than p65 under the conditions tested. We can define specificity of binding to a DNA sequence as the ratio of the apparent affinity for a specific DNA-binding site sequence divided by the apparent affinity for nonspecific DNA. For p50, this comparison is complicated by the finding that the ionic strength dependence for specific and nonspecific binding sites is different. The data show that the specificity of p50 for a specific sequence decreases as ionic strength increases, because nonspecific binding is less sensitive to ionic strength than specific binding. A comparison of p50 specificity at several sodium acetate concentrations shows that at low ionic strength (~50 mM) the specificity of binding is between 100 and 4000 depending on the site, but a physiological ionic strength the specificity is significantly lower (5-10). The significance of this result is unclear, however, these experiments were done using short DNA-binding sites (18 nucleotides) and we have observed that the apparent affinity of DNA binding is very sensitive to binding site length (data not shown). It is possible that the apparent affinity dependence on length is a consequence of the nonspecific affinity and is a mechanism used by p50 to find specific DNA-binding sites. Thus, in the context of a longer DNA sequence the apparent affinity of a specific site might increase, which would increase the overall specificity. However, further analysis of this interaction would be required to test this hypothesis.

The selectivity of different forms of NF-kappa B has been previously described (9). Since the amino acid sequences of the monomers are different, it was assumed that the selectivity arose exclusively from different amino acid-nucleotide base contacts. Recent descriptions of the structures of NF-kappa B-DNA complexes have shown that many hydrogen bonds are made between the protein monomer and the bases in the DNA-binding site (13-16). Five amino acids in the p50 monomer appear to make direct hydrogen bonds to bases and two of these are different between p50 and p65 (His67 right-arrow Ala; and Lys244 right-arrow Arg) allowing for differences in hydrogen bonding patterns. The reported structures for Rel family proteins (13-16) show that the major DNA recognition amino acids are found on a loop between two beta -sheet structures. In the absence of DNA, this loop has been suggested to be flexible since it is not contained in a defined secondary structure motif. These data suggest that the DNA-binding site of Rel family proteins is likely to be flexible enough to allow some movement when associated to DNA-binding site sequences other than those that are found in the crystal structures. Recently, the crystal structure of the p65-DNA complex has been described to have structural differences in the DNA-binding domains of the two monomers (16). The ionic strength dependence of the affinity of a protein for DNA is related to the number of ions released to solvent upon complex formation (22). If the number of ions released changes, it may be related to a change in the structure of the protein. The change in the ionic strength dependence of NF-kappa B-DNA complex formation described in this report, suggest that the structure of the p50-DNA complex containing either the beta -interferon or the hu Igkappa sites are different. These results are consistent with the structural changes observed in the p65 homodimer crystals. Thus, this data provides physical evidence for flexibility in the DNA-binding site of p50 that depends on the DNA-binding site sequence. In addition the data suggests that, along with different amino acid contacts, the structure of the protein may be altered when bound to different DNA-binding site sequences.

Thus, these data are consistent with a model of NF-kappa B binding to DNA that allows some variations in the DNA-binding domain of the protein to accommodate different DNA-binding site sequences. This model might explain why only some NF-kappa B DNA-binding sites promote cooperative interactions with other transcription factors or accessory proteins like high mobility group-I(Y) (31). It is also possible that the alternative structures are associated with NF-kappa B transcriptional activity directly, as some strong p65 homodimer DNA-binding sites are found to be very poor activators of transcription (32). Therefore, the alternative structures of NF-kappa B complexes may add another level of regulation to transcription by this complex by using the DNA-binding site as an allosteric effector of NF-kappa B activity.

    ACKNOWLEDGEMENTS

I thank Drs. Stephen Hunt and Gary McMaster for support during this project and Dr. W. Thomas Mueller for production of the recombinant p50 and p65.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 734-622-5090; Fax: 734-622-5970; E-mail: joseph.menetski@wl.com.

2 J. B. Marine and J. P. Menetski, manuscript in preparation.

3 J. B. Marine and J. P. Menetski, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: HIV, human immunodeficiency virus; GST, glutathione S-transferase; TBP, TATA-binding protein; hu, human.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Lenardo, M. J., and Baltimore, D. (1989) Cell 58, 227-229[CrossRef][Medline] [Order article via Infotrieve]
2. Nabel, G., and Baltimore, D. (1987) Nature 326, 711-713[CrossRef][Medline] [Order article via Infotrieve]
3. Niller, H. H., and Hennighausen, L. (1991) Nucleic Acids Res. 19, 3715-3721[Abstract/Free Full Text]
4. Sha, W. C., Liou, H. C., Tuomanen, E. I., and Baltimore, D. (1995) Cell 80, 321-330[CrossRef][Medline] [Order article via Infotrieve]
5. Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R. P., Lira, S. A., and Bravo, R. (1995) Cell 80, 331-340[CrossRef][Medline] [Order article via Infotrieve]
6. Doi, T. S., Takahashi, T., Taguchi, O., Azuma, T., and Obata, Y. (1997) J. Exp. Med. 185, 953-961[Abstract/Free Full Text]
7. Gilmore, T. D. (1992) Cancer Surv 15, 69-87[Medline] [Order article via Infotrieve]
8. Urban, M. B., and Baeuerle, P. A. (1991) New Biol. 3, 279-288[Medline] [Order article via Infotrieve]
9. Kunsch, C., Ruben, S. M., and Rosen, C. A. (1992) Mol. Cell. Biol. 12, 4412-4421[Abstract/Free Full Text]
10. Perkins, N. D., Schmid, R. M., Duckett, C. S., Leung, K., Rice, N. R., and Nabel, G. J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 1529-1533[Abstract/Free Full Text]
11. Muroi, M., Muroi, Y., Yamamoto, K., and Suzuki, T. (1993) J. Biol. Chem. 268, 19534-19539[Abstract/Free Full Text]
12. Schmid, R. M., Liptay, S., Betts, J. C., and Nabel, G. J. (1994) J. Biol. Chem. 269, 32162-32167[Abstract/Free Full Text]
13. Muller, C. W., Rey, F. A., Sodeoka, M., Verdine, G. L., and Harrison, S. C. (1995) Nature 373, 311-317[CrossRef][Medline] [Order article via Infotrieve]
14. Ghosh, G., van Duyne, G., Ghosh, S., and Sigler, P. B. (1995) Nature 373, 303-310[CrossRef][Medline] [Order article via Infotrieve]
15. Cramer, P., Larson, C. J., Verdine, G. L., and Muller, C. W. (1997) EMBO J. 16, 7078-7090[CrossRef][Medline] [Order article via Infotrieve]
16. Chen, Y. Q., Ghosh, S., and Ghosh, G. (1998) Nat. Struct. Biol. 5, 67-73[CrossRef][Medline] [Order article via Infotrieve]
17. Chen, F. E., Huang, D. B., Chen, Y. Q., and Ghosh, G. (1998) Nature 391, 410-413[CrossRef][Medline] [Order article via Infotrieve]
18. Perkins, N. D., Agranoff, A. B., Pascal, E., and Nabel, G. J. (1994) Mol. Cell. Biol. 14, 6570-6583[Abstract/Free Full Text]
19. Duckett, C. S., Perkins, N. D., Kowalik, T. F., Schmid, R. M., Huang, E. S., Baldwin, A. S., Jr., and Nabel, G. J. (1993) Mol. Cell. Biol. 13, 1315-1322[Abstract/Free Full Text]
20. Riggs, A. D., Suzuki, H., and Bourgeoss, S. (1970) J. Mol. Biol. 48, 67-83[CrossRef][Medline] [Order article via Infotrieve]
21. deHaseth, P. L., Lohman, T. M., and Record, M. T., Jr. (1977) Biochemistry 16, 4783-4790[CrossRef][Medline] [Order article via Infotrieve]
22. Record, M. T., Jr., Anderson, C. F., and Lohman, T. M. (1978) Q. Rev. Biophys. 11, 103-178[Medline] [Order article via Infotrieve]
23. Record, M. T., Jr., Lohman, M. L., and De Haseth, P. (1976) J. Mol. Biol. 107, 145-158[CrossRef][Medline] [Order article via Infotrieve]
24. Menetski, J. P., Varghese, A., and Kowalczykowski, S. C. (1992) J. Biol. Chem. 267, 10400-10404[Abstract/Free Full Text]
25. Leirmo, S., Harrison, C., Cayley, D. S., Burgess, R. R., and Record, M. T., Jr. (1987) Biochemistry 26, 2095-2101[CrossRef][Medline] [Order article via Infotrieve]
26. Gohlke, C., Murchie, A. I., Lilley, D. M., and Clegg, R. M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11660-11664[Abstract/Free Full Text]
27. Heyduk, E., Heyduk, T., Claus, P., and Wisniewski, J. R. (1997) J. Biol. Chem. 272, 19763-197670[Abstract/Free Full Text]
28. Parkhurst, K. M., Brenowitz, M., and Parkhurst, L. J. (1996) Biochemistry 35, 7459-7465[CrossRef][Medline] [Order article via Infotrieve]
29. Heyduk, T., and Lee, J. C. (1992) Biochemistry 31, 5165-5171[CrossRef][Medline] [Order article via Infotrieve]
30. Starr, D. B., Hoopes, B. C., and Hawley, D. K. (1995) J. Mol. Biol. 250, 434-446[CrossRef][Medline] [Order article via Infotrieve]
31. Thanos, D., and Maniatis, T. (1992) Cell 71, 777-789[CrossRef][Medline] [Order article via Infotrieve]
32. Casolaro, V., Georas, S. N., Song, Z., Zubkoff, I. D., Abdulkadir, S. A., Thanos, D., and Ono, S. J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11623-11627[Abstract/Free Full Text]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
P. K. Bhavsar, M. B. Sukkar, N. Khorasani, K.-Y. Lee, and K. F. Chung
Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-{kappa}B
FASEB J, June 1, 2008; 22(6): 1807 - 1816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Trainor, R. Ghirlando, and M. A. Simpson
GATA Zinc Finger Interactions Modulate DNA Binding and Transactivation
J. Biol. Chem., September 1, 2000; 275(36): 28157 - 28166.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-L. Baert, C. Beaudoin, L. Coutte, and Y. de Launoit
ERM Transactivation Is Up-regulated by the Repression of DNA Binding after the PKA Phosphorylation of a Consensus Site at the Edge of the ETS Domain
J. Biol. Chem., January 4, 2002; 277(2): 1002 - 1012.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menetski, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menetski, J. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.